Network Solutions
By Thomas Insel on
Dr. Insel talks about how NIMH’s RAISE study is exploring an integrated, multi-component approach to health care for schizophrenia.
By Thomas Insel on
Dr. Insel talks about how NIMH’s RAISE study is exploring an integrated, multi-component approach to health care for schizophrenia.
By Thomas Insel on
Dr. Insel introduces an innovative approach that one group is taking to speed up the dissemination of research results into clinical practice.
By Thomas Insel on
Dr. Insel describes a new behavioral treatment for a neurologically based disorder that has traditionally been difficult to treat.
By Thomas Insel on
Dr. Insel discusses the crisis of medication development for mental disorders.
By Thomas Insel on
Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.
By Thomas Insel on
While fewer medical students are choosing psychiatry in the U.K., in the U.S. psychiatry is attracting increasing numbers of elite MD-PhD students who want to do research. These young scientists are committed to developing a new scientific basis for clinical care.
By Thomas Insel on
Dr. Insel discusses opportunities for treatment development.
By Thomas Insel on
Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.
By Thomas Insel on
Dr. Insel discusses opportunities for treatment development.
By Thomas Insel on
Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors
By Thomas Insel on
Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.
By Thomas Insel on
Dr. Insel reflects on an exciting neuroscience conference where an increasing interest in neuropsychiatric disorders was evident.
By Thomas Insel on
Dr. Insel provides a vision for future clinical research.
By Thomas Insel on
Dr. Insel discusses the evolution of clinical research and changing priorities in clinical research funding.
By Thomas Insel on
Increasing evidence linking strep infection to OCD in children suggests that microbiomics may prove an important research area for understanding and treating mental disorders.
By Thomas Insel on
Dr. insel discusses two important initiatives that will have a broad impact on NIMH’s clinical research portfolio.